Tag: Ed Silverman
FDA Memo Rebuffs Many Suggestions for Expanding Off-label Marketing
"After weeks of anticipation, the FDA has issued a lengthy memo about the extent to which so-called off-label information about medicines may be disseminated...
“Does the FDA have a High Enough Standard for Drug Approvals?”
Last week STAT hosted a panel of experts, asking “Is the Food and Drug Administration’s approval process broken?”
Article →Â
“Why We Shouldn’t Trade a Weakened FDA for More Medical Research...
Ed Silverman at STAT reports that Congress has linked increased research funding to “fast-track” approval procedures. “By linking the extra funds to speedier approvals,...
